Single Ascending Dose Study of Safety and Tolerability of Sarilumab and Methotrexate in Japanese Patients With Rheumatoid Arthritis

NCT01850680 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: sarilumab SAR153191 (REGN88)
DRUG: placebo
DRUG: methotrexate
DRUG: folic acid

Sponsor

Sanofi

Collaborators

[object Object]